Ion Peptides review: catalogue, lab reports, shipping (2026)
What Ion Peptides publishes about its catalogue, its lab reports, its shipping and its payment terms, read from ionpeptide.com on September 16, 2026and checked against FDA's warning letter database. A listing is not an endorsement, and we do not verify purity, identity or what is in any individual vial.
This page reports what published studies found. It is not medical advice, no provider-patient relationship is created by reading it, and nothing here is a recommendation to use any compound. Talk with a licensed clinician about your own situation. Read the full disclaimer.
At a glance
| Status | Open |
|---|---|
| Lab reports | Not published We could not confirm a certificate policy from the pages we could read. |
| Ships to | Not published |
| Payment | Accepted payment methods are not published on the pages we could read. Confirm at checkout. |
| FDA warning letters | None found in FDA's warning letter database when we searched it on September 16, 2026. |
| Website | ionpeptide.com |
Sponsored links below; we may earn a commission. Details.
Visit Ion PeptidesPlain link. We are not an affiliate of Ion Peptides at this time.
Compounds listed
Products this vendor lists that match a compound we track, read from its own catalogue. Coded or abbreviated product names are not mapped, because that would mean guessing at what is in the vial.
- NAD+
- GLOW blend
- KLOW blend
- KPV
- Selank
- Semax
- MOTS-c
- PT-141
- 5-Amino-1MQ
- DSIP
- Epitalon
- LL-37
- Thymosin alpha-1
What we found
Ion Peptides trades at ionpeptide.com and serves a browser-check challenge to automated requests, so the catalogue below was read through a rendering fetch on 2026-09-16 rather than a plain one. The company's published contact address is in Sheridan, Wyoming, a registered-agent address used by a large number of unrelated businesses, so it does not tell a reader where anything is made or shipped from.
The catalogue runs to roughly 74 items and abbreviates or codes a striking share of them: Sermo, Tesa, Ipamo, Cag, KSPTN, OXTCN, MLT I and MLT II, and the GLP-1-class products as ION-1S, ION-2T and ION-3R. We have mapped only the products the site names in full, so the compound list here is shorter than the catalogue and deliberately so.
On testing the site says every batch is supported by COA documentation for traceability, and describes HPLC for purity, mass spectrometry for molecular weight and quality control linked to batch numbers. We could not find a public report library, so the certificate status is recorded as unknown. Fulfilment is described as same-day for orders placed before 6pm EST on weekdays or 3pm Saturday.
What “research use only” means, and the market it sits in
Every vendor in this section sells material labelled for research, laboratory or analytical use and not for human consumption. That label is not a formality and it is not a loophole. It is the seller stating that the product has not been through the approval or compounding systems that govern medicines, and that it is not intended for a person.
The market is under active enforcement. FDA's public warning letter database shows a continuing run of unapproved-new-drug and misbranding letters to peptide sellers: Gram Peptides and Pink Pony Peptides on 31 March 2026, Wholesale Peptide on 17 June 2026, and five on a single day, 24 August 2026, to Peak Performance Peptides, Royal Peptides, NuScience Peptides, Peptide Partners and Tex Peptides. Of the vendors profiled here, one appears in that database: Swiss Chems, letter dated 10 December 2024.
Criminal exposure is real as well. In the Northern District of Indiana, the operators of Paradigm Peptides entered guilty pleas on 10 December 2025 over products sold as SARMs that in fact contained testosterone and over unapproved peptide and hCG products; both were sentenced in July 2026. Separately, payment processors have been withdrawing from this category, which is why so many storefronts route buyers to crypto, Zelle or bank wire rather than a card.
There is a lawful route for several of these compounds, and it is not this one. At its meeting on 23–24 July 2026, FDA's Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV and TB-500 (8–6, one abstention) and MOTS-c (7–5, two abstentions) for the section 503A bulk drug substances list. That vote is advisory: FDA decides, and where compounding proceeds it runs through a licensed prescriber and a licensed pharmacy, not a research storefront.
Sources for this section
- FDA warning letter database (searched 16 September 2026)
- FDA warning letter to Swisschems, 10 December 2024 (MARCS-CMS 695663)
- FDA warning letter to Gram Peptides, 31 March 2026
- FDA warning letter to Peak Performance Peptides, 24 August 2026
- United States v. Matthew Kawa, N.D. Indiana (guilty pleas entered 10 December 2025)
- FDA Pharmacy Compounding Advisory Committee, 2026 meeting materials (meeting of 23–24 July 2026)
Compound profiles carry the regulatory status for each substance, and online peptide therapy covers the prescription route.
Frequently asked questions
Is Ion Peptides legit?
The storefront is live and the catalogue is readable, and the site describes batch-level testing. It also codes many of its product names and lists a Wyoming registered-agent address, neither of which helps a reader verify anything. It is a research-chemical seller.
What are ION-1S, ION-2T and ION-3R?
They are the site's own codes for its GLP-1-class products. The site does not state which compound each one contains, and we do not guess, so none of them is mapped to a compound profile here.
What do Ion Peptides reviews say?
We do not aggregate reviews for research vendors. What we verified on 2026-09-16 is the catalogue, the site's testing language, its stated fulfilment cutoffs and the absence of the company from FDA's warning letter database.
Does Ion Peptides have a discount code?
No standing public code was shown on the pages we read, and we do not issue codes for any vendor listed here.
Does Ion Peptides publish certificates of analysis?
It says every batch is supported by certificate documentation and describes HPLC and mass-spectrometry testing, but no public report library was reachable. Ask for the report matching the lot number.
Want it prescribed instead?
Nothing on this page is a route to a peptide for a person. The lawful route runs through a licensed prescriber and a licensed pharmacy, and for several of these compounds it exists today. Our telehealth section compares programs on prescriber type, pharmacy model, whether labs are required, state coverage and published pricing, and each compound profile states what can lawfully be prescribed or compounded right now.
Where the research stands
Our research digests summarise new studies against their primary sources, and are peptides legal explains the difference between an approved drug, a compounded preparation and a research chemical.